Jay Wish, MD
Nephrology · Indianapolis, INNPI 1851311922
Payments from drug & device makers
Across 487 payments — averaging $1030.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Akebia Therapeutics Inc$130K
- GSK$121K
- AstraZeneca$98K
- Calliditas Therapeutics US Inc.$57K
- Rockwell Medical, Inc.$27K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$20K
- plus $50K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Akebia Therapeutics Inc | 130 | $130,194 |
| GSK | 81 | $120,636 |
| AstraZeneca | 100 | $98,088 |
| Calliditas Therapeutics US Inc. | 59 | $56,635 |
| Rockwell Medical, Inc. | 21 | $26,614 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 13 | $19,842 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 6 | $15,012 |
| Ardelyx, Inc. | 11 | $6,461 |
| Vifor (international) Ltd. | 2 | $5,464 |
| CSL Behring | 3 | $5,124 |
| Astrazeneca UK Limited | 3 | $5,000 |
| Amgen | 13 | $4,838 |
| Vifor Pharma, Inc. | 8 | $3,050 |
| Fresenius USA Marketing, Inc. | 5 | $1,338 |
| Otsuka America Pharmaceutical, Inc. | 6 | $1,040 |
| Novartis | 10 | $798 |
| Pfizer | 1 | $780 |
| American Regent | 4 | $300 |
| Apellis Pharmaceuticals, Inc. | 2 | $104 |
| Mallinckrodt Hospital Products Inc. | 1 | $88 |
| Bayer | 1 | $60 |
| Mallinckrodt Enterprises LLC | 3 | $56 |
| Travere Therapeutics, Inc. | 1 | $51 |
| Corcept Therapeutics | 1 | $49 |
| Quanta Dialysis Technologies Inc | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
How this compares
$501,673 in reported general payments places this provider in the 95th percentile of 238 nephrology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Indianapolis
- Rajiv AgarwalIndianapolis$1.2M
- Bruce MolitorisIndianapolis$471K
- Arjun SinhaIndianapolis$315K
- Sharon MoeIndianapolis$298K
- Kenneth LimIndianapolis$238K
- Tim TaberIndianapolis$198K
- Melissa AndersonIndianapolis$146K
- Asif SharfuddinIndianapolis$146K
- Michael KrausIndianapolis$92K
- Nupur GuptaIndianapolis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.